Skip to main content
Veterinary Medicines

DOG-VAC DHL

Suspended
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain ATCC 23470, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain ATCC 43642, Inactivated
  • Canine distemper virus, strain Rockborn, Live
  • Canine adenovirus 2, strain Manhattan, Live

Product identification

Medicine name:
DOG-VAC DHL
Active substance:
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain ATCC 23470, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain ATCC 43642, Inactivated
  • Canine distemper virus, strain Rockborn, Live
  • Canine adenovirus 2, strain Manhattan, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain ATCC 23470, Inactivated
    80.00
    percentage protection
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain ATCC 43642, Inactivated
    80.00
    percentage protection
    /
    1.00
    millilitre(s)
  • Canine distemper virus, strain Rockborn, Live
    4.00
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, strain Manhattan, Live
    6.00
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ02
Authorisation status:
  • Suspended
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Ovejero S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Ovejero S.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 3504 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."